Mycophenolate Mofetil Powder, For Suspension
Product Images NDC 16571-282

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 16571-282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Structure)

Chemical structure of Mycophenolate Mofetil, a pharmaceutical active ingredient. The diagram shows various rings, bonds, and functional groups consistent with the molecular structure of Mycophenolate Mofetil.*

FDA Label Image

Bottle-adapter.jpg (Bottle Adapter)

Illustration showing the components of a drug bottle labeled as a child-resistant bottle cap, a bottle adapter, and the bottle itself. The diagram highlights how these parts fit together, likely for a powder for suspension medication container.*

FDA Label Image

Oral Dispenser.jpg (Oral Dispenser)

An instructional diagram labeled 'Oral Dispenser' showing a syringe-style device with three parts identified: blue plunger, barrel with measurement markings, and tip. Used for oral administration dosing.*

FDA Label Image

Fig-2- Withdraw.jpg (Fig 2 Withdraw)

An instructional line drawing labeled Figure 2 showing two hands preparing a liquid medication dose. One hand holds a bottle upside down, while the other hand holds a syringe or dosing device to draw up the medication from the bottle. The image appears to guide proper technique for measuring oral suspension.*

FDA Label Image

Mycophenolate-container.jpg (Mycophenolate Container)

Label for Mycophenolate Mofetil for Oral Suspension, USP 200 mg/mL from Rising Pharma Holdings, Inc. The label includes storage instructions, dosing information, pharmacist guidance, and preparation directions after constitution. The label shows an NDC of 16571-282-17 and mentions the product is for oral suspension with 200 mg of mycophenolate mofetil per mL after constitution. There is a barcode and space for lot and expiration date details.*

FDA Label Image

Mycophenolate-carton.jpg (Mycophenolate Carton)

Packaging label for Mycophenolate Mofetil for Oral Suspension, USP 200 mg/mL powder for suspension. The label indicates the product is from Rising Pharma Holdings, Inc., with a total contents volume of 175 mL after constitution. It includes preparation instructions, storage conditions, and a barcode. The product is packaged in a 225 mL bottle with accessories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.